Navigation Links
Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies
Date:4/14/2008

t is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the quarterly report on Form 10-Q for the quarter ended January 31, 2008. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
11. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)... , July 1, 2015  Celsion Corporation (NASDAQ: ... announced that Michael H. Tardugno , Chairman, President ... Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July 8, 2015, ... at Le Parker Meridien Hotel located at 119 W. ... 10019. A copy of the presentation will ...
(Date:7/1/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... and chief executive officer, is scheduled to present ... an update on Egalet,s marketed product SPRIX ... product OXAYDO ™ (oxycodone HCI, USP) tablets ...
Breaking Medicine Technology:The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... June 1, 2011 Reportlinker.com ... research report is available in ... Interventional Neurology - Global ... Market Forecasts to 2017 ...
... 2011 Repro-Med Systems, Inc., (REPR.PK) announced today that ... Administration (FDA) to begin U.S. marketing of its new ... the HIgh Flo™ RMS Subcutaneous Needle Sets.  The needle ... subcutaneous tissue.  The needle sets have previously been approved ...
Cached Medicine Technology:Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12FDA Approves Marketing of RMS Subcutaneous Needle Sets 2FDA Approves Marketing of RMS Subcutaneous Needle Sets 3
(Date:7/1/2015)... ... July 01, 2015 , ... A Priority Setting Partnership put ... ten list they hope will guide future mesothelioma research. Surviving Mesothelioma has just ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Amada Senior ... a new office in the greater Phoenix area – their Mesa, Arizona location ... to senior care with their purchase of the rights to the area after years ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the only full-service ... national chief nursing officer recruitment for Capital Health in Pennington, ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... ... July 01, 2015 , ... After conducting ... E. Smith, Tri-City Medical Center in Oceanside, Calif., has hired Cheryle ... of leading organization-wide compliance adaptation efforts and growing a focus on risk management, ...
(Date:7/1/2015)... ... July 01, 2015 , ... Research published in the ... smartphone app to test eyesight was just as accurate as those from standard paper-based ... and Tropical Medicine is responsible for the development of the test, which does not ...
Breaking Medicine News(10 mins):Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3
... July 9 TCS Healthcare Technologies (TCS), an industry leader ... that TCS is expanding its software hosting options through a ... provider. , , Rob Pock, TCS Founder and CEO, ... AnyWare, a care management software application developed by TCS and ...
... the impression that "Spice Gold" is strongly addictive. In ... ( Dtsch Arzteblatt Int 2009: 106[27]: 464-7), Ulrich ... describe a young man who developed physical withdrawal symptoms ... a dependence syndrome. Since 22 January 2009, ...
... , PALM CITY, Fla., July 9 Connectyx (Other OTC: ... the Company will be hosting a Nationwide Teleconference today, July ... During the call, Ronn Schuman, Connectyx President and CEO will ... and strategic partnerships the Company has developed over the last ...
... 10 adults who stutter have been denied a job or promotion ... teased, according to a new survey by the National Stuttering Association. ... , , Results of the survey were announced today ... , While there is no cure for stuttering, the survey of ...
... Smith recently announced the promotions of Jeff Greer to vice ... president of purchasing and trade relations. These appointments are ... leadership to maximize growth potential. , , ... sales efforts to expand into new service sectors. In ...
... ongoing recession and associated job cuts is creating a ... slowing health insurer growth and pressuring profitability, according to ... , "Conning projects that health care costs will ... margins through 2011," said Terence Martin, analyst at Conning ...
Cached Medicine News:Health News:TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM) 2Health News:TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM) 3Health News:Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results 2Health News:Survey: Speech Therapy Helps, But People Who Stutter Suffer Discrimination 2Health News:H. D. Smith Promotes Leadership to Fill Two Senior Roles 2Health News:Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 2
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... offers easy operation, maintenance, and training. Whether you ... to the powerful VITROS 5,1 FS, the VITROS ... right the first time. Its that simple. , ... and easy-to-use. The VITROS 350 comes complete with ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
Medicine Products: